Experienced Management Team: P3 was founded and is led by one of the most experienced management teams in population health.
FORESIGHT HEALTH FULL
P3 enters markets with payor and provider partnerships to rapidly scale member growth while developing a full network of primary care, specialty, and ancillary providers. Rapidly Scalable, Capital-Light Model: P3’s capital efficient growth approach leverages the existing installed physician base across the U.S., which enables accelerated market entry while maintaining the preexisting patient and physician relationship.P3 currently operates in 11 markets across four states and expects to add three to five new markets annually to drive 35% patient growth over the long-term through a mix of payor and provider opportunities. Large Addressable Market for Medicare Advantage Patients: Substantial market opportunity to partner with physicians & payors that serve the 60 million estimated Medicare eligible beneficiaries in P3’s rapidly growing core $300 billion Medicare Advantage Market.P3 is dedicated to transforming healthcare for patients, providers, and payors with a proven physician-affiliated model that delivers high-quality, low-cost care to Medicare Advantage members. Empowering Value-Based Care: Founded and led by physicians, P3 is a team of doctors, clinicians and support service professionals with a shared passion for delivering value-based care.P3 is a portfolio company of Chicago Pacific Founders who provided P3’s initial and growth capital. P3 believes its extensive experience managing Medicare Advantage (MA) populations in global risk arrangements drives its differentiated model, which simultaneously improves care and decreases costs. P3 is a patient-centered and physician-led population health management company that supports providers, physicians, and practices in their journey from traditional volume-based models to value-based systems of care and wellness. Upon closing of the transaction, the combined entity will be renamed P3 Health Partners and is expected to remain listed on the Nasdaq Capital Market. (NASDAQ: FORE) (“Foresight”) have entered into a definitive agreement which would result in P3 becoming a publicly listed company. NEW YORK, (GLOBE NEWSWIRE) - P3 Health Partners (“P3”) and Foresight Acquisition Corp.
Transaction Includes an Over $200 Million Fully Committed Common Stock Private Investment at $10 Per Share Including Participation From Funds and Accounts Managed by Fidelity Management & Research Company LLC and Janus Henderson Investors. Estimated Post-Transaction Enterprise Value of $2.3 Billion With Over $180 Million in Cash to Fund Growth. How do we have we react in order to do help shape changed use at an early stage? To do this, we are taking a look into the future of the fields of medical and biotechnology, pharmaceuticals, insurance and pension provision, nutrition, sport and lifestyle, and this year we are cooperating with the Gesundheitswirtschaft Hamburg and Life Science Nord.- Transaction to Publicly List P3 Health Partners, a Patient-Centered and Physician-Led Population Health Management Company Delivering Value-Based Care.
FORESIGHT HEALTH SOFTWARE
Together with companies from the healthcare industry, software and hardware manufacturers at the interface between content and tech and above all larger media houses, we would like to investigate how the reception of content in the health sector will change in the future. In which environments and scenarios will content be used in the future and which media and technologies will it be used for? Where are health offers needed and consumed in the future? What challenges, but also innovation potential, do the content and healthcare sectors share? Which business areas and developments can be identified at their interface, which trends and utopias can be formulated?
0 kommentar(er)
